ConductScience.org, home

Paper7340985

A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry.

Hill BT and 4 others. Cancer Chemother Pharmacol, 1981. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry. Papers, record 7340985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7340985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A comparative assessment of the in vitro effects of drugs on cells by means of colony assays or flow microfluorimetry.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1981
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
2.39
iCite
Revised in PubMed
2026-10-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hill BTB T
2Whelan RDR D
3Rupniak HTH T
4Dennis LYL Y
5Rosholt MAM A

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Cell SurvivalMajor topic
NeuroblastomaMajor topic
Animals
Cells, Cultured
Colony-Forming Units Assay
Dose-Response Relationship, Drug
Flow Cytometry
Mice
Neoplasms, Experimental

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1658097Cell cycle stage-dependent induction of G2 phase arrest by different antitumor agents.Eur J Cancer (1965)1978https://conductscience.org/library/papers/658097PubMed
24133816Cell-cycle analysis in 20 minutes.Science1974https://conductscience.org/library/papers/4133816PubMed
37193870In vitro drug assay: pharmacologic considerations.Prog Clin Biol Res1980https://conductscience.org/library/papers/7193870PubMed
449354Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.J Cell Biol1975https://conductscience.org/library/papers/49354PubMed
549004Methods and applications of flow systems for analysis and sorting of mammalian cells.Methods Cell Biol1975https://conductscience.org/library/papers/49004PubMed
677475Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.N Engl J Med1978https://conductscience.org/library/papers/77475PubMed
7144604Flow microfluorometric estimation of G1 and G2 chalone inhibition of the JB-1 tumour cell cycle in vitro.Exp Cell Res1977https://conductscience.org/library/papers/144604PubMed
81277123Comparison of in vitro methods to determine drug-induced cell lethality.Cancer Res1976https://conductscience.org/library/papers/1277123PubMed
9498131Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder.Cancer Res1979https://conductscience.org/library/papers/498131PubMed
105912615Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.J Natl Cancer Inst1966https://conductscience.org/library/papers/5912615PubMed
116943380Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.J Natl Cancer Inst1981https://conductscience.org/library/papers/6943380PubMed
12687520Growth of human tumour cell colonies from biopsies using two soft-agar techniques.Br J Cancer1978https://conductscience.org/library/papers/687520PubMed
131057547Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts.J Cell Biol1975https://conductscience.org/library/papers/1057547PubMed
146105478In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy.Lancet1980https://conductscience.org/library/papers/6105478PubMed
151026329Age-dependent survival and cell-cycle progression of cultured cells exposed to chemotherapeutic drugs.Cancer Treat Rep1976https://conductscience.org/library/papers/1026329PubMed
16210939Direct cloning of human ovarian carcinoma cells in agar.Cancer Res1978https://conductscience.org/library/papers/210939PubMed
176987066Lethal and kinetic effects of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine).Eur J Cancer (1965)1980https://conductscience.org/library/papers/6987066PubMed
18421720Patterns of cell survival following treatment with antitumor agents in vitro.Eur J Cancer (1965)1979https://conductscience.org/library/papers/421720PubMed

Download CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
25929919Efficacy of oral Etoposide in pretreated metastatic breast cancer: a multicenter phase 2 study.Medicine (Baltimore)2015https://conductscience.org/library/papers/25929919PubMed
8286205Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease.Br J Cancer1994https://conductscience.org/library/papers/8286205PubMed
8070033Schedule-dependent topoisomerase II-inhibiting drugs.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8070033PubMed
8070031Etoposide dosage and pharmacodynamics.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8070031PubMed
7647335Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer.Breast Cancer Res Treat1995https://conductscience.org/library/papers/7647335PubMed
7497587Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7497587PubMed
6861265Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6861265PubMed
6540761Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro.Invest New Drugs1984https://conductscience.org/library/papers/6540761PubMed
6488441Pharmacokinetic study of VM26 given as a prolonged IV infusion to ovarian cancer patients.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6488441PubMed
6371370Predictive tests in cancer chemotherapy. A reappraisal.Klin Wochenschr1984https://conductscience.org/library/papers/6371370PubMed
4039488Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.Urol Res1985https://conductscience.org/library/papers/4039488PubMed
3815726Effects of N-trifluoroacetyladriamycin-14-valerate (AD-32) on human bladder tumor cell lines.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3815726PubMed
3624301Kinetic and survival response of the M14 cell line to lonidamine associated with adriamycin or hyperthermia.J Cancer Res Clin Oncol1987https://conductscience.org/library/papers/3624301PubMed
3297462The clinical pharmacology of etoposide and teniposide.Clin Pharmacokinet1987https://conductscience.org/library/papers/3297462PubMed
2824081Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/2824081PubMed
2720889Initial and early effects of adriamycin in murine sarcoma 180 cannot be restored in a resistant subline by increasing the uptake and external concentration of the drug.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2720889PubMed
2452031Degradation of melphalan in vitro: rationale for the use of continuous exposure in chemosensitivity assays.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/2452031PubMed
1643692Do anticancer agents reach the tumor target in the human brain?Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1643692PubMed
1600600Toxicity and metabolism of 3'-deoxyadenosine N1-oxide in mice and Ehrlich ascites tumor cells.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1600600PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7340985

GET https://conductscience.org/api/papers/v1/7340985/authors